Siemens builds on diabetes testing

By staff writers

May 14, 2019 -- Siemens Healthineers has released a hemoglobin A1c (HbA1c) test that it believes will help clinicians diagnose and monitor patients with diabetes evaluated with its Atellica CH diagnostic unit.

The Atellica CH enzymatic hemoglobin A1c assay offers accurate results that may be used for the management of patients with diabetes, Siemens said in a May 14 statement. The HbA1c rollout is part of a broader company effort in laboratory and point-of-care systems aimed at harmonizing tests.

Researchers link protein group to end-stage renal disease
The presence of a group of inflammatory proteins could signify that patients with diabetic kidney disease may be at risk of progressing to end-stage renal...

Copyright © 2019

Last Updated np 5/15/2019 12:21:21 PM